Abbonarsi

Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases - 05/07/23

Doi : 10.1016/j.jpeds.2023.113408 
Chi-Bo Chen, MD 1, , Jacob Shujui Hsu, PhD 2, , Pei-Lung Chen, MD, PhD 2, 3, 4, Jia-Feng Wu, MD, PhD 1, Huei-Ying Li, PhD 5, Bang-Yu Liou, PhD 1, Mei-Hwei Chang, MD 1, Yen-Hsuan Ni, MD, PhD 1, 5, 6, Wuh-Liang Hwu, MD, PhD 1, 2, 3, Yin-Hsiu Chien, MD, PhD 1, 2, 3, Yen-Yin Chou, MD 7, Yao-Jong Yang, MD, PhD 7, Ni-Chung Lee, MD, PhD 1, 3, , Huey-Ling Chen, MD, PhD 1, 6, 8, ,
1 Department of Pediatrics, National Taiwan University College of Medicine and Children’s Hospital, Taipei, Taiwan 
2 Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei, Taiwan 
3 Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan 
4 Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan 
5 Medical Microbiome Center, National Taiwan University College of Medicine, Taipei, Taiwan 
6 Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan 
7 Department of Pediatrics, National Cheng Kung University Hospital, Taipei, Taiwan 
8 Department of Medical Education & Bioethics, National Taiwan University College of Medicine, Taipei, Taiwan 

Reprint requests: Huey-Ling Chen, MD, PhD, Department of Pediatrics, National Taiwan University College of Medicine and Children’s Hospital, 17F, No. 8, Chung-Shan South Rd, Taipei 100, Taiwan.Department of PediatricsNational Taiwan University College of Medicine and Children’s Hospital17F, No. 8, Chung-Shan South RdTaipei100Taiwan

Abstract

Objectives

To determine how advanced genetic analysis methods may help in clinical diagnosis.

Study design

We report a combined genetic diagnosis approach for patients with clinical suspicion of genetic liver diseases in a tertiary referral center, using tools either tier 1: Sanger sequencing on SLC2SA13, ATP8B1, ABCB11, ABCB4, and JAG1 genes, tier 2: panel-based next generation sequencing (NGS), or tier 3: whole-exome sequencing (WES) analysis.

Results

In a total of 374 patients undergoing genetic analysis, 175 patients received tier 1 Sanger sequencing based on phenotypic suspicion, and pathogenic variants were identified in 38 patients (21.7%). Tier 2 included 216 patients (39 of tier 1-negative patients) who received panel-based NGS, and pathogenic variants were identified in 60 (27.8%). In tier 3, 41 patients received WES analysis, and 20 (48.8%) obtained genetic diagnosis. Pathogenic variants were detected in 6 of 19 (31.6%) who tested negative in tier 2, and a greater detection rate in 14 of 22 (63.6%) patients with deteriorating/multiorgan disease receiving one-step WES (P = .041). The overall disease spectrum is comprised of 35 genetic defects; 90% of genes belong to the functional categories of small molecule metabolism, ciliopathy, bile duct development, and membrane transport. Only 13 (37%) genetic diseases were detected in more than 2 families. A hypothetical approach using a small panel-based NGS can serve as the first tier with diagnostic yield of 27.8% (98/352).

Conclusions

NGS based genetic test using a combined panel-WES approach is efficient for the diagnosis of the highly diverse genetic liver diseases.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : children, infant, jaundice, cholestasis, progressive familial intrahepatic cholestasis

Abbreviations : NGS, NICCD, PCR, PFIC, WES


Mappa


 This study was financially supported through grants from the Ministry of Science and Technology, Taiwan (109-2314-B-002-159-MY3), and National Taiwan University Hospital (107-S3917, 108-S4392). The authors have no conflicts of interest to disclose.


© 2023  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 258

Articolo 113408- luglio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Prevalence of Invasive Bacterial Infection in Hypothermic Young Infants: A Multisite Study
  • Jennifer L. Raffaele, Meenu Sharma, Stephanie Berger, Meredith Mitchell, Clifton Lee, John Morrison, Madhuri Prasad, Monica D. Combs, Kira Molas-Torreblanca, Julie K. Wood, Annalise Van Meurs, Kathryn Westphal, Ali Sawani, Sumeet L. Banker, Jennifer Lee, Coleton King, Elizabeth E. Halvorson, Nicholas M. Potisek, Hypothermic Young Infant Research Collaborative, Saylor McCartor, Vignesh Doraiswamy, Sanford Williams
| Articolo seguente Articolo seguente
  • Cost-Effectiveness of Strategies to Identify Children with Perinatally Acquired Hepatitis C Infection
  • Eric W. Hall, Lakshmi Panagiotakopoulos, Carolyn Wester, Noele Nelson, Amy L. Sandul

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.